Cbd oil for bile duct cancer


Yup, do a search for cannabis oil and you’ll get all kinds of info on it. My mother in law was taking it for 6 months while on chemo, and hasn’t been on any treatment except the cannabis for the past 6 months because everything was stable. Make sure you get the high thc oil, not the cbd. The cbd is used for pain and nausea to treat the side effects of chemo and cancer. The high thc oil is the one that claims to kill the cancer.

Thank you for your replies. I live in Scotland so i dont know where i would even start to be able to get THC oil. I need it more urgently than beng able to start growing my own! CBD oil is now legal here but there sint a pint in getting that if it wont be in the least bit effective?

I’m going to disagree with the thc/cbd ratio discussed here. My research shows that the cannabis oil needs the thc levels to be over 90% for it to be effective against cancer. My mil had 6 months of gem/cis chemo, showed a huge reduction in the size of the tumors, and now has gone the past 6 months without any kind of therapy except the cannabis oil. She’s only taking a little more than a maintenance dose, about 4 grams a month, but for the past 6 months, it has remained stable and hasn’t gotten worse, so they aren’t going to start any new therapy until it changes for the worse. She is getting the oil made with girl scout cookie, which is already about 28% thc.

For cancer or any other critical illness you need (1) find a reputable dispensary or cannabis maker (2) what I mean by reputable is the product needs to be accompanied by lab results which clearly outines the % of CBD, % THC, % CBDA,% THCA, a% of other terpenes of the plant AS WELL AS the potency (anything below 60% is not worth it) (3) For Cancer you need the whole plant extract (google entourage effect) not just one isolated cannabidiol molecule whehter it is CBD or THC, it MUST be the whole plant. For instance, my dog and I use a high CBD oil which is 20:1 (meaning 20 parts CBD to 1 THC). For cancer, the best ratio out there is 1:1 meaning 1 part CBD and 1 part THC.

If you live in a state where you can get a medical card, please do so. Also search for cannabis doctors that can best guide you with dosing and ratios. I can give you two names of two that work out of California but they can do phone consults worldwide (note: by law they cannot sell you cannabis or give a medical card but they can sure guide you where to get them) one is Dr. Allan Frankel out of Santa Monica Los Angeles CA and the other one is Calla Spring Wellness out of San Francisco both are experts in dealing with cancer diagnosis. Just for your own education google Zelda Theraupeutics Pancreatic Cancer Clinical Trial so you can read how cannabis researchers have paired up with oncologist in clinical trials abroad (Australia) and recently they have made progress in the area of breast, brain, and pancreatic cancer.

I hope this helps.

does anyone have an update on how the cannabis oil is working? is using CBD oil/Charlottes web as effective? i dont know where i could get a trustworthy source of the THC oil from

Wow. $1200/3 grams? $400 a gram? Wow. I’m getting it for my MIL from a neighbor that’s a caregiver at $30/gram. And this is the high THC strain, not the CBD stuff you can buy online. We just bought a second 30 gram dosage that should last a few months for $800.

Rosi, most doctors don’t embrace cannabis for medicinal use. It is a new pharmaceutical technology that is evolving on it’s own since the federal government has continued to foot drag on rescheduling the drug. The only thing that has drawn the attention of lawmakers is the potential source of money. What other lifesaving drugs are taxed by every level of government that can put their hand out ? Are chemotherapy drugs heavily taxed by federal, state, and municipal taxes ? This makes it too costly for many patients that need it, I sponsored a woman with cholangiocarcinoma that lived in New York and cannabis oil was 1200.00 for 3 grams, sadly too costly for an unproven treatment for her. Her cancer took her and she never was able to even try it. Medical cannabis should be tax exempt for all patients that need it, recreational is a different story, tax it like all other vices, however medical cannabis should be available and affordable to all. I have used cannabis since my surgery, and I cannot say it is why my cancer hasn’t returned, however it is part of what I have done, I changed my diet to more healthy foods, no grease lower fat, daily exercise in fresh outdoor air if possible, and just take care of yourself. I have gotten twelve years of cancer free life after cc, I have had no chemo, no radiation, just surgery and what I have mentioned here, and I believe cannabis research will unlock a cure for cancer or treatments with fewer side effects than chemo, I wish you the best, Pat

See also  Best cbd oil for moderate paim

Right now my MIL is on a 3 month break from the first 6 months of being on gem/cis chemo. She had a bought of the flu so she didn’t take the cannibis oil capsules for a couple weeks. She’s going to have another cat scan at the end of February to see what has happened in the last 3 months, then determine if there’s a next phase of treatment. So far, the results are fantastic, but we will see in a month. One thing to mention, people talk about taking cannabis for pain and inflammation, or to help with the side effects of chemo. There’s two types of cannabis and it depends on the strain the oil is made from. The most common you hear of it the CBD oil. That’s for pain, nausea, etc. You shouldn’t feel the psychotropic effects from that. That’s the type that most doctors will tell you are fine and you can take it. The other strain is from the sativa strains of the plants. That’s the one Rick Simpson made famous. It’s very high THC. It won’t help with pain or nausea, but many have reported that it cures the cancer. That’s the one that doctors say are rubbish, there’s no such thing, blah, blah. Well what do you expect them to say? Do you have any clue how much money is made treating cancer in the US? There will never be a cure for cancer made by a pharmaceutical company. They aren’t in the business to cure one of the most profitable diseases in the world. Have you read about how numerous doctors that have been using cannabis to cure cancers, and are starting to publish papers have ended up dead in the past year? Google how many holistic doctors have died of “suspicious” circumstances. In the case of my MIL, she is taking the high THC, sativa strain. It give some psychotropic effects but she takes it at night and sleeps it off. Her inoperable, incurable cancer that she had only 8 months to live, is now in month 10. 75% of it has mysteriously disappeared. The doctors hoped to just stop it from getting any worse, and have no explanation as to why it’s getting better. In total, the 8 months of cannabis cost about $1500. So even if it didn’t work, it’s not like we were out a bunch of money. Now that I said this, if I end up “mysteriously” dying tomorrow, you’ll know why! Good luck!

  • This reply was modified 4 years, 3 months ago by taylorjm .

Sorry to hear about your mom and my only 2 cents is that Cannabis does work when properly dosed by an Medical Doctor who specializes in it and when it is early in the cancer treatment. Unfortunately, Cannabis is not a one-size-fits all miracle and with its classification of Schedule 1 drug it is very hard for Research and Development in this country (Elli Lily the drug manufacturer in the 1930’s used to sell cannabis tinctures and they were marketed for various illnesses including cancer, it is beyond me why the turn of events into a schedule 1 drug, maybe loss of profits since a plant cannot be patented). That is why the research happening outside of the USA is so important as clinical trials are happening in Spain, Australia, Chile, etc..for different ailments and I am glad to see they are including pets as well.

Cannabis can alleviate some pain and inflammation and thus is a wonderful supplement at any point specially during hospice. And I will say it over and over again for THERAUPEUTIC dosage people need a medical doctor (for example, Dr. Allan Franke out of L.A, Dr. Bonnie Goldstein out of L.A, Calla Springs Wellness out of San Francisco along with Mara Gordon from Aunt Zelda just to mention a few reputable ones)….if you want to learn more search for Mara Gordon on youtube and she is the founder of Zelda Theraupeutics in Australia which is conducting clinical trials on different diseases (including pets) and Mara usually goes around the globe and sits with medical doctors, researchers, etc…so she is a key resource to learn from.

Yes! cancer takes years to form and imaging can only pick it up when the tumor is of a certain size.

Thanks for the question, as this is the same one I have.

To briefly share the story, even though I have multiple posts. Mom was inoperable and we decided on no treatment, only palliative care. This is going over a year after diagnosis, but found out with research that she has had this awful tumor for about four years not, obviously getting worse. The worst part was those stent exchanges! Anyway, long story short, last recommendation was hospice. She was prescribed Norco and Dilaudid for different levels of pain, Dilaudid when it’s unbearable. Atarax for jaundice itching, which isn’t as effective anymore so relies on Norco. Now since in obvious circumstances there is nothing to lose, I will check into cannabis for pain management. This is something so difficult to even convince her to use. Once she tries it, I will share. Seriously, if someone is recommended at hospice what can one lose? Either it works or doesn’t and that’s it! This has been an endless challenge, and more power to everyone who is fighting this illness. I really have to thank everyone, patient and caretaker who tries hard to help.

  • This reply was modified 4 years, 3 months ago by positivity .
See also  Cbd oil for pediatric epilepsy seizures

Curious to know if the continued used of Cannabis is still proving to work for your Mother in Law….if you can share any updates, it will be highly appreciated.

Cannabis Research for Cholangiocarcinoma

Cholangiocarcinoma, also known as Bile Duct Cancer, is a rare cancer that forms in the bile ducts.
A bile duct is a tube that carries bile (fluid made by the liver) between the liver and gallbladder and the small intestine. Intrahepatic cholangiocarcinoma is found inside the liver. Extrahepatic cholangiocarcinoma is found outside the liver. Also called bile duct cancer.

The bile ducts are tubes that carry bile between the liver and gallbladder and the intestine. Bile duct cancer is also called cholangiocarcinoma. When it begins in the bile ducts inside the liver, it is called intrahepatic cholangiocarcinoma. When it begins in the bile ducts outside the liver, it is called extrahepatic cholangiocarcinoma. Extrahepatic cholangiocarcinoma is much more common than intrahepatic cholangiocarcinoma. — National Cancer Institute

Below is a Library of Cannabis Research Studies for Cholangiocarcinoma, also known as Bile Duct Cancer.

Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients

Pharmaceuticals | November 2020
Abstract: “In the last decade the use of medical cannabis (MC) for palliative cancer treatment has risen. However, the choice between products is arbitrary and most patients are using Tetrahydrocannabinol (THC)-dominant cannabis products. In this study, we aimed to assess the short-term outcomes of MC treatment prescribed by oncologists in relation to the type of cannabis they receive. A comparative analysis was used to assess the di erences in treatment e ectiveness and safety between THC-dominant (n = 56, 52%), cannabidiol (CBD)-dominant (n = 19, 18%), and mixed (n = 33, 30%) MC treatments. Oncology patients (n = 108) reported on multiple symptoms in baseline questionnaires, initiated MC treatment, and completed a one-month follow-up. Most parameters improved significantly from baseline, including pain intensity, a ective and sensory pain, sleep quality and duration, cancer distress, and both physical and psychological symptom burden. There was no significant di erence between the three MC treatments in the MC-related safety profile. Generally, there were no di erences between the three MC treatments in pain intensity and in most secondary outcomes. Unexpectedly, CBD-dominant oil treatments were similar to THC-dominant treatments in their beneficial e ects for most secondary outcomes. THC-dominant treatments showed significant superiority in their beneficial e ect only in sleep duration compared to CBD-dominant treatments. This work provides evidence that, though patients usually consume THC-dominant products, caregivers should also consider CBD-dominant products as a useful treatment for cancer-related symptoms.” — Study

GPCRs: Emerging Anti-Cancer Drug Targets

Cellular Signalling | September 2017
Abstract: “G protein-coupled receptors (GPCRs) constitute the largest and most diverse protein family in the human genome with over 800 members identified to date. They play critical roles in numerous cellular and physiological processes, including cell proliferation, differentiation, neurotransmission, development and apoptosis. Consequently, aberrant receptor activity has been demonstrated in numerous disorders/diseases, and as a result GPCRs have become the most successful drug target class in pharmaceuticals treating a wide variety of indications such as pain, inflammation, neurobiological and metabolic disorders. Many independent studies have also demonstrated a key role for GPCRs in tumourigenesis, establishing their involvement in cancer initiation, progression, and metastasis. Given the growing appreciation of the role(s) that GPCRs play in cancer pathogenesis, it is surprising to note that very few GPCRs have been effectively exploited in pursuit of anti-cancer therapies. The present review provides a broad overview of the roles that various GPCRs play in cancer growth and development, highlighting the potential of pharmacologically modulating these receptors for the development of novel anti-cancer therapeutics.” — Study

Cannabinoids as Anticancer Drugs

Advances in Pharmacology | June 2017
Abstract: “The endocannabinoid system encompassing cannabinoid receptors, endogenous receptor ligands (endocannabinoids), as well as enzymes conferring the synthesis and degradation of endocannabinoids has emerged as a considerable target for pharmacotherapeutical approaches of numerous diseases. Besides palliative effects of cannabinoids used in cancer treatment, phytocannabinoids, synthetic agonists, as well as substances that increase endogenous endocannabinoid levels have gained interest as potential agents for systemic cancer treatment. Accordingly, cannabinoid compounds have been reported to inhibit tumor growth and spreading in numerous rodent models. The underlying mechanisms include induction of apoptosis, autophagy, and cell cycle arrest in tumor cells as well as inhibition of tumor cell invasion and angiogenic features of endothelial cells. In addition, cannabinoids have been shown to suppress epithelial-to-mesenchymal transition, to enhance tumor immune surveillance, and to support chemotherapeutics’ effects on drug-resistant cancer cells. However, unwanted side effects include psychoactivity and possibly pathogenic effects on liver health. Other cannabinoids such as the nonpsychoactive cannabidiol exert a comparatively good safety profile while exhibiting considerable anticancer properties. So far experience with anticarcinogenic effects of cannabinoids is confined to in vitro studies and animal models. Although a bench-to-bedside conversion remains to be established, the current knowledge suggests cannabinoid compounds to serve as a group of drugs that may offer significant advantages for patients suffering from cancer diseases. The present review summarizes the role of the endocannabinoid system and cannabinoid compounds in tumor progression.” — Study

See also  Best cbd vape oil for anxiety uk

Promises and Pitfalls of Cannabinoids as Agents with Potential Anticancer Efficacy

Journal of Neurology & Neuromedicine | September 2016
Abstract: “The endocannabinoid system is extensively studied in neuroscience and clinical use of cannabinoid derivatives as substances with remarkable spasmolytic effects in multiple sclerosis and antiemetic potential in cancer therapy as well as pain-relieving properties is broadly acknowledged. However, it becomes increasingly apparent, that in addition cannabinoids exert manifold functions in various organ systems, such as the immune system, the reproductive or cardiovascular system among others. Moreover, interactions with signaling pathways involved in programmed cell death, angiogenesis, metastasis or anti-tumor immunity make it highly suggestive that cannabinoids may have therapeutic potential in the treatment of cancer. Indeed, detailed reports have repeatedly shown an cancer efficacy in solid and hematologic tumor models, best characterized in human gliomas. Anecdotal evidence of blast control in a young patient with acute myeloid leukemia has led us to systematically investigate the potential use of cannabinoids in the treatment of acute leukemia. These data are summarized herein in the context of key data regarding an cancer efficacy of cannabinoids.” — Review

Cannabinoids as Therapeutic Agents in Cancer: Current Status and Future Implications

Oncotarget | July 2014
Abstract: “The pharmacological importance of cannabinoids has been in study for several years. Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant, (b) endogenous as well as (c) synthetic cannabinoids. Though cannabinoids are clinically used for anti-palliative effects, recent studies open a promising possibility as anti-cancer agents. They have been shown to possess anti-proliferative and anti-angiogenic effects in vitro as well as in vivo in different cancer models. Cannabinoids regulate key cell signaling pathways that are involved in cell survival, invasion, angiogenesis, metastasis, etc. There is more focus on CB1 and CB2, the two cannabinoid receptors which are activated by most of the cannabinoids. In this review article, we will focus on a broad range of cannabinoids, their receptor dependent and receptor independent functional roles against various cancer types with respect to growth, metastasis, energy metabolism, immune environment, stemness and future perspectives in exploring new possible therapeutic opportunities.” — Study

The Dual Effects Of Delta(9)-Tetrahydrocannabinol On Cholangiocarcinoma Cells: Anti-invasion Activity At Low Concentration And Apoptosis Induction At High Concentration

Cancer Investigation | May 2010
Abstract: “Currently, only gemcitabine plus platinum demonstrates the considerable activity for cholangiocarcinoma. The anticancer effect of Delta (9)-tetrahydrocannabinol (THC), the principal active component of cannabinoids has been demonstrated in various kinds of cancers. We therefore evaluate the antitumor effects of THC on cholangiocarcinoma cells. Both cholangiocarcinoma cell lines and surgical specimens from cholangiocarcinoma patients expressed cannabinoid receptors. THC inhibited cell proliferation, migration and invasion, and induced cell apoptosis. THC also decreased actin polymerization and reduced tumor cell survival in anoikis assay. pMEK1/2 and pAkt demonstrated the lower extent than untreated cells. Consequently, THC is potentially used to retard cholangiocarcinoma cell growth and metastasis.” — Study

Cannabis Research Library

Over 1000 studies covering over 130 topics compiled for easy browsing.

FAIR USE NOTICE: This site contains copyrighted material the use of which: has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.